Open Interest and Volume Dynamics
The latest data reveals that Lupin’s open interest in derivatives rose sharply by 3,304 contracts, a 12.32% increase from the previous figure of 26,813 to 30,117. This surge in OI is accompanied by a robust volume of 26,510 contracts, indicating heightened trading activity and fresh positions being established. The futures value stands at approximately Rs. 25,391 lakhs, while the options segment shows an enormous notional value of Rs. 24,526.87 crores, culminating in a total derivatives value of Rs. 29,418 lakhs. Such figures underscore the growing interest in Lupin’s derivatives, suggesting that traders are positioning for significant price movements.
Price Performance and Technical Indicators
Lupin’s underlying stock price currently trades at Rs. 2,347, having recently achieved a new 52-week high of Rs. 2,369.5. The stock has recorded a 0.50% return in the last trading session, outperforming the sector’s 0.21% gain and contrasting with the Sensex’s decline of 0.86%. Notably, Lupin has been on a two-day consecutive gain streak, delivering a cumulative return of 1.83% during this period. The stock is trading above all key moving averages – 5-day, 20-day, 50-day, 100-day, and 200-day – signalling a strong uptrend and positive momentum.
Investor Participation and Liquidity
Investor engagement has intensified, as evidenced by the delivery volume of 10.96 lakh shares on 5 March, which surged by 86.81% compared to the five-day average delivery volume. This rising investor participation highlights growing confidence in the stock’s prospects. Additionally, Lupin’s liquidity remains robust, with the stock capable of supporting trade sizes up to Rs. 5.23 crore based on 2% of the five-day average traded value, making it an attractive option for institutional and retail traders alike.
Handpicked from 50, scrutinized by experts – Our recent selection, this Mid Cap from Bank - Public, is already delivering results. Don't miss next month's pick!
- - Expert-scrutinized selection
- - Already delivering results
- - Monthly focused approach
Market Positioning and Directional Bets
The sharp increase in open interest alongside rising volumes suggests that market participants are actively building positions in Lupin’s derivatives, likely anticipating further upward price movement. The stock’s Mojo Score of 78.0 and a current Mojo Grade of Buy, recently downgraded from Strong Buy on 16 February 2026, reflect a cautiously optimistic outlook. While the downgrade indicates some moderation in enthusiasm, the overall sentiment remains positive, supported by Lupin’s strong fundamentals and sectoral tailwinds.
Given the pharmaceutical sector’s resilience and Lupin’s mid-cap status with a market capitalisation of Rs. 1,07,725 crore, investors appear to be favouring the stock as a growth play. The increase in open interest by over 12% is a clear sign of fresh capital inflows, possibly from institutional traders or hedge funds positioning for a sustained rally. The futures and options data further corroborate this, with substantial notional values indicating significant hedging and speculative activity.
Comparative Sector and Market Context
In comparison to the broader sector, Lupin’s performance is inline or slightly better, with the stock’s 0.50% daily return outpacing the sector’s 0.21% gain. This relative strength is notable given the Sensex’s decline of 0.86% on the same day, suggesting that Lupin is attracting safe-haven flows amid broader market volatility. The stock’s ability to maintain gains above all major moving averages further strengthens its technical case.
Risks and Considerations
Despite the positive signals, investors should remain mindful of potential risks. The recent downgrade from Strong Buy to Buy indicates some caution, possibly due to valuation concerns or sector-specific headwinds such as regulatory changes or pricing pressures. Additionally, the large open interest in options could lead to increased volatility, especially around expiry dates. Traders should monitor volume and price action closely to gauge whether the bullish momentum sustains or if profit-taking emerges.
Want to dive deeper on Lupin Ltd.? There's a real-time research report diving right into the fundamentals, valuations, peer comparison, financials, technicals and much more!
- - Real-time research report
- - Complete fundamental analysis
- - Peer comparison included
Outlook and Investor Takeaway
Lupin Ltd.’s recent surge in open interest and volume in the derivatives market, coupled with its strong price performance and technical positioning, point towards a bullish market consensus. The stock’s ability to sustain gains above key moving averages and outperform its sector peers amid a declining Sensex highlights its relative strength. Investors with a medium to long-term horizon may find Lupin an attractive proposition, especially given its solid fundamentals and growing investor participation.
However, the recent downgrade in Mojo Grade from Strong Buy to Buy suggests a need for cautious optimism. Market participants should keep an eye on evolving sector dynamics, regulatory developments, and overall market sentiment. The elevated open interest also implies that volatility could increase, offering both opportunities and risks for traders.
In summary, Lupin Ltd. remains a compelling stock within the Pharmaceuticals & Biotechnology sector, supported by robust derivatives activity and positive technical signals. The current market positioning indicates that investors are placing directional bets favouring further upside, making it a key stock to watch in the coming weeks.
Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →
